290 related articles for article (PubMed ID: 12236626)
1. Additional dopamine reuptake inhibition attenuates vigilance impairment induced by serotonin reuptake inhibition in man.
Schmitt JA; Ramaekers JG; Kruizinga MJ; van Boxtel MP; Vuurman EF; Riedel WJ
J Psychopharmacol; 2002 Sep; 16(3):207-14. PubMed ID: 12236626
[TBL] [Abstract][Full Text] [Related]
2. Specific serotonergic reuptake inhibition impairs vigilance performance acutely and after subchronic treatment.
Riedel WJ; Eikmans K; Heldens A; Schmitt JA
J Psychopharmacol; 2005 Jan; 19(1):12-20. PubMed ID: 15671124
[TBL] [Abstract][Full Text] [Related]
3. Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
Fava M; Judge R; Hoog SL; Nilsson ME; Koke SC
J Clin Psychiatry; 2000 Nov; 61(11):863-7. PubMed ID: 11105740
[TBL] [Abstract][Full Text] [Related]
4. Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
Ahrold TK; Meston CM
J Sex Marital Ther; 2009; 35(4):311-9. PubMed ID: 19466669
[TBL] [Abstract][Full Text] [Related]
5. Antidepressant-induced sexual dysfunction during treatment with moclobemide, paroxetine, sertraline, and venlafaxine.
Kennedy SH; Eisfeld BS; Dickens SE; Bacchiochi JR; Bagby RM
J Clin Psychiatry; 2000 Apr; 61(4):276-81. PubMed ID: 10830148
[TBL] [Abstract][Full Text] [Related]
6. Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors.
Schmitt JA; Kruizinga MJ; Riedel WJ
J Psychopharmacol; 2001 Sep; 15(3):173-9. PubMed ID: 11565624
[TBL] [Abstract][Full Text] [Related]
7. Cross-sensitivity between paroxetine and sertraline.
Warnock CA; Azadian AG
Ann Pharmacother; 2002 Apr; 36(4):631-3. PubMed ID: 11918512
[TBL] [Abstract][Full Text] [Related]
8. Serotonergic function in major depression and effect of sertraline and paroxetine treatment.
Stain-Malmgren R; Khoury AE; Aberg-Wistedt A; Tham A
Int Clin Psychopharmacol; 2001 Mar; 16(2):93-101. PubMed ID: 11236074
[TBL] [Abstract][Full Text] [Related]
9. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Rosenbaum JF; Fava M; Hoog SL; Ascroft RC; Krebs WB
Biol Psychiatry; 1998 Jul; 44(2):77-87. PubMed ID: 9646889
[TBL] [Abstract][Full Text] [Related]
10. Double-blind controlled trial of sertraline versus paroxetine in the treatment of delusional depression.
Zanardi R; Franchini L; Gasperini M; Perez J; Smeraldi E
Am J Psychiatry; 1996 Dec; 153(12):1631-3. PubMed ID: 8942464
[TBL] [Abstract][Full Text] [Related]
11. Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
Kroenke K; West SL; Swindle R; Gilsenan A; Eckert GJ; Dolor R; Stang P; Zhou XH; Hays R; Weinberger M
JAMA; 2001 Dec; 286(23):2947-55. PubMed ID: 11743835
[TBL] [Abstract][Full Text] [Related]
12. Selective serotonin reuptake inhibitor treatment for generalized anxiety disorder: a double-blind, prospective comparison between paroxetine and sertraline.
Ball SG; Kuhn A; Wall D; Shekhar A; Goddard AW
J Clin Psychiatry; 2005 Jan; 66(1):94-9. PubMed ID: 15669894
[TBL] [Abstract][Full Text] [Related]
13. Incidence of early anxiety aggravation in trials of selective serotonin reuptake inhibitors in depression.
Näslund J; Hieronymus F; Emilsson JF; Lisinski A; Nilsson S; Eriksson E
Acta Psychiatr Scand; 2017 Oct; 136(4):343-351. PubMed ID: 28859218
[TBL] [Abstract][Full Text] [Related]
14. Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment.
Michelson D; Amsterdam J; Apter J; Fava M; Londborg P; Tamura R; Pagh L
Psychoneuroendocrinology; 2000 Feb; 25(2):169-77. PubMed ID: 10674280
[TBL] [Abstract][Full Text] [Related]
15. Serotonergic antidepressants and urinary incontinence.
Votolato NA; Stern S; Caputo RM
Int Urogynecol J Pelvic Floor Dysfunct; 2000 Dec; 11(6):386-8. PubMed ID: 11147747
[TBL] [Abstract][Full Text] [Related]
16. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
Foster RH; Goa KL
CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
[TBL] [Abstract][Full Text] [Related]
17. A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline.
Croft H; Settle E; Houser T; Batey SR; Donahue RM; Ascher JA
Clin Ther; 1999 Apr; 21(4):643-58. PubMed ID: 10363731
[TBL] [Abstract][Full Text] [Related]
18. Withdrawal syndromes after paroxetine and sertraline discontinuation.
Fava GA; Grandi S
J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
[No Abstract] [Full Text] [Related]
19. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
Hjalmarsson L; Corcos M; Jeammet P
Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
[TBL] [Abstract][Full Text] [Related]
20. Paroxetine, sertraline, and fluvoxamine: new selective serotonin reuptake inhibitors.
Grimsley SR; Jann MW
Clin Pharm; 1992 Nov; 11(11):930-57. PubMed ID: 1464219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
